{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:23:49Z","timestamp":1790713429090,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP18K09870"],"award-info":[{"award-number":["JP18K09870"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19K10137"],"award-info":[{"award-number":["JP19K10137"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jphs.2021.05.011","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T13:24:24Z","timestamp":1622121864000},"page":"40-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Local administration of ReveromycinA ointment suppressed alveolar bone loss in mice"],"prefix":"10.1016","volume":"147","author":[{"given":"Ken","family":"Miyazawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Tabuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Kako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Kawatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Osada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatsuhiko","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigemi","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jphs.2021.05.011_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2329\/perio.48.10","article-title":"Relationship between periodontal and osteoporotic parameters in postmenopausal women","volume":"48","author":"Sugiishi","year":"2006","journal-title":"J\u00a0Jpn Soc Periodontol"},{"issue":"4","key":"10.1016\/j.jphs.2021.05.011_bib2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1600-0765.2011.01365.x","article-title":"Relationships among bone turnover, renal function and periodontal disease in elderly Japanese","volume":"46","author":"Yoshihara","year":"2011","journal-title":"J\u00a0Periodontal Res"},{"issue":"6717","key":"10.1016\/j.jphs.2021.05.011_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.jphs.2021.05.011_bib4","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1101\/gad.13.18.2412","article-title":"RANK is essential for osteoclast and lymph node development","volume":"13","author":"Dougall","year":"1999","journal-title":"Genes Dev"},{"issue":"4","key":"10.1016\/j.jphs.2021.05.011_bib5","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1073\/pnas.97.4.1566","article-title":"RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism","volume":"97","author":"Li","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.jphs.2021.05.011_bib6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.jphs.2021.05.011_bib7","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification","volume":"12","author":"Bucay","year":"1998","journal-title":"Genes Dev"},{"issue":"3","key":"10.1016\/j.jphs.2021.05.011_bib8","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1006\/bbrc.1998.8697","article-title":"Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor\/osteoprotegerin","volume":"247","author":"Mizuno","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"10.1016\/j.jphs.2021.05.011_bib9","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1177\/0022034512451026","article-title":"Effect of Reveromycin A on experimental tooth movement in OPG-\/- mice","volume":"91","author":"Tanaka","year":"2012","journal-title":"J\u00a0Dent Res"},{"issue":"3","key":"10.1016\/j.jphs.2021.05.011_bib10","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ajodo.2013.04.016","article-title":"Stabilization of tooth movement by administration of Reveromycin A to osteoprotegerin-deficient knockout mice","volume":"144","author":"Yabumoto","year":"2013","journal-title":"Am J Orthod Dentofacial Orthop"},{"issue":"4","key":"10.1016\/j.jphs.2021.05.011_bib11","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2329\/perio.37.725","article-title":"Studies on clinical and microbiological evaluation of minocycline hydrochloride with a local drug delivery system in the acute phase of adult periodontitis","volume":"37","author":"Noguchi","year":"1995","journal-title":"J\u00a0Jpn Soc Periodontol"},{"issue":"1","key":"10.1016\/j.jphs.2021.05.011_bib12","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2329\/perio.30.206","article-title":"Local administration of minocycline for periodontitis double blind comparative study of LS-007","volume":"30","author":"Murayama","year":"1998","journal-title":"J\u00a0Jpn Soc Periodontol"},{"key":"10.1016\/j.jphs.2021.05.011_bib13","first-page":"1569","article-title":"Inflammation and bone loss in periodontal disease","volume":"79","author":"Cochran","year":"2008","journal-title":"J\u00a0Periodontol"},{"issue":"2","key":"10.1016\/j.jphs.2021.05.011_bib14","doi-asserted-by":"crossref","first-page":"259","DOI":"10.7164\/antibiotics.44.259","article-title":"Reveromycin A, a new antibiotic which inhibits the mitogenic activity of epidermal growth factor","volume":"44","author":"Osada","year":"1991","journal-title":"J\u00a0Antibiot (Tokyo)"},{"issue":"12","key":"10.1016\/j.jphs.2021.05.011_bib15","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.1073\/pnas.0505663103","article-title":"Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclasts","volume":"103","author":"Woo","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"24 Pt 1","key":"10.1016\/j.jphs.2021.05.011_bib16","doi-asserted-by":"crossref","first-page":"8822","DOI":"10.1158\/1078-0432.CCR-05-1335","article-title":"Reveromycin A inhibits osteolytic bone metastasis of small-cell lung cancer cells, SBC-5, through an antiosteoclastic activity","volume":"11","author":"Muguruma","year":"2005","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.jphs.2021.05.011_bib17","doi-asserted-by":"crossref","first-page":"16510","DOI":"10.1038\/srep16510","article-title":"Reveromycin A administration prevents alveolar bone loss in osteoprotegerin knockout mice with periodontal disease","volume":"5","author":"Mizuno","year":"2015","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.jphs.2021.05.011_bib18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2485\/jhtb.23.255","article-title":"A\u00a0new experimental mouse model of periodontitis using an orthodontic ligature wire","volume":"23","author":"Mizuno","year":"2014","journal-title":"J\u00a0Hard Tissue Biol"},{"key":"10.1016\/j.jphs.2021.05.011_bib19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1538\/expanim.60.481","article-title":"Effect of three types of mixed anesthetic agents alternate to ketamine in mice","volume":"60","author":"Kawai","year":"2011","journal-title":"Exp Anim"},{"issue":"2","key":"10.1016\/j.jphs.2021.05.011_bib20","first-page":"273","article-title":"Three-dimensional micro-computed tomographic imaging of alveolar bone in experimental bone loss or repair","volume":"78","author":"Park","year":"2007","journal-title":"J\u00a0Periodontol"},{"issue":"3","key":"10.1016\/j.jphs.2021.05.011_bib21","first-page":"550","article-title":"Actinobacillus actinomycetemcomitans lipopolysaccharide-mediated experimental bone loss model for aggressive periodontitis","volume":"78","author":"Rogers","year":"2007","journal-title":"J\u00a0Periodontol"},{"key":"10.1016\/j.jphs.2021.05.011_bib22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3109\/13697137.2010.500749","article-title":"Periodontitis and osteoporosis: a systematic review","volume":"13","author":"Mart\u00ednez-Maestre","year":"2010","journal-title":"Climacteric"},{"issue":"4","key":"10.1016\/j.jphs.2021.05.011_bib23","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2329\/perio.56.367","article-title":"Potentiality of periodontal pharmacotherapy","volume":"56","author":"Gomi","year":"2014","journal-title":"J\u00a0Jpn Soc Periodontol"},{"issue":"6","key":"10.1016\/j.jphs.2021.05.011_bib24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1172\/JCI10763","article-title":"Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection","volume":"106","author":"Teng","year":"2000","journal-title":"J\u00a0Clin Invest"},{"issue":"7","key":"10.1016\/j.jphs.2021.05.011_bib25","first-page":"1300","article-title":"RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis","volume":"78","author":"Qiming","year":"2007","journal-title":"J\u00a0Periodontol"},{"issue":"8","key":"10.1016\/j.jphs.2021.05.011_bib26","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1248\/yakushi.122.589","article-title":"Evaluation of the permeability of corticosteroid in hairless mouse and hairless micro pig skin from admixture of commercially available corticosteroid ointments and\/or creams","volume":"122","author":"Ohtani","year":"2002","journal-title":"Yakugaku Zasshi"},{"issue":"6","key":"10.1016\/j.jphs.2021.05.011_bib27","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/1523-1747.ep12462031","article-title":"Hairless mouse skin is limited as a model for assessing the effects of penetration enhancers in human skin","volume":"90","author":"John","year":"1988","journal-title":"J\u00a0Invest Dermatol"},{"issue":"4","key":"10.1016\/j.jphs.2021.05.011_bib28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2329\/perio.46.253","article-title":"Role of measurements of probing depth and attachment level in periodontal patients","volume":"46","author":"Tomofuji","year":"2004","journal-title":"J\u00a0Jpn Soc Periodontol"},{"issue":"1","key":"10.1016\/j.jphs.2021.05.011_bib29","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4049\/jimmunol.160.1.403","article-title":"IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis","volume":"160","author":"Assuma","year":"1998","journal-title":"J\u00a0Immunol"},{"issue":"3","key":"10.1016\/j.jphs.2021.05.011_bib30","first-page":"453","article-title":"Cytokine profiles in crevicular fluid during orthodontic tooth movement of short and long durations","volume":"78","author":"Ren","year":"2007","journal-title":"J\u00a0Periodontol"},{"issue":"5","key":"10.1016\/j.jphs.2021.05.011_bib31","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1600-0722.2006.00387.x","article-title":"Composition changes in gingival crevicular fluid during orthodontic tooth movement: comparisons between tension and compression sides","volume":"114","author":"Dudic","year":"2006","journal-title":"Eur J Oral Sci"},{"issue":"1","key":"10.1016\/j.jphs.2021.05.011_bib32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40510-014-0065-6","article-title":"Effects of orthodontic force on cytokine and receptor levels in gingival crevicular fluid: a systematic review","volume":"15","author":"Kapoor","year":"2014","journal-title":"Prog Orthod"},{"issue":"9","key":"10.1016\/j.jphs.2021.05.011_bib33","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J\u00a0Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.jphs.2021.05.011_bib34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.joms.2006.10.061","article-title":"Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia","volume":"65","author":"Mavrokokki","year":"2007","journal-title":"J\u00a0Oral Maxillofac Surg"},{"issue":"11","key":"10.1016\/j.jphs.2021.05.011_bib35","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.joms.2011.03.051","article-title":"Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan","volume":"69","author":"Urade","year":"2011","journal-title":"J\u00a0Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.jphs.2021.05.011_bib36","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2177\/jsci.36.162","article-title":"Development and pharmacological effects of anti-RANKL monoclonal antibody drug Denosumab","volume":"36","author":"Takami","year":"2013","journal-title":"Jpn J Clin Immunol"},{"issue":"4","key":"10.1016\/j.jphs.2021.05.011_bib37","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","article-title":"Denosumab and bisphosphonates: different mechanisms of action and effects","volume":"48","author":"Baron","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.jphs.2021.05.011_bib38","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","volume":"23","author":"Saad","year":"2012","journal-title":"Ann Oncol"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861321000530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861321000530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:01:22Z","timestamp":1761163282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861321000530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1347861321000530"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2021.05.011","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Local administration of ReveromycinA ointment suppressed alveolar bone loss in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2021.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}